Pharmacogenomics: accessing important alleles by imputation from commercial genome-wide SNP arrays
“Pharmacogenomics: accessing important alleles by imputation from commercial genome-wide SNP arrays”, vol. 13, pp. 5713-5721, 2014.
, Personalized medicine is becoming a medical reality, as important genotype-phenotype relationships are being unraveled. The availability of pharmacogenomic data is a key element of individualized care. In this study, we explored genotype imputation as a means to infer important pharmacogenomic alleles from a regular commercially available genome-wide SNP array. Using these arrays as a starting point can reduce testing costs, increasing access to these pharmacogenomic data and still retain a larger amount of genome-wide information.